Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huason Pharmaceutical, officially known as Zhejiang Huason Pharmaceutical Co., Ltd., is a leading Chinese pharmaceutical manufacturer specializing in the research, development, and production of high-quality generic drugs and Active Pharmaceutical Ingredients (APIs). The company maintains a diverse product portfolio focused on anti-infectives, cardiovascular health, endocrinology, and gastroenterology. With large-scale GMP-certified facilities in Jinhua, Zhejiang, Huason is vertically integrated, producing both sterile cephalosporin APIs and finished dosage forms such as injections and oral solids. The company serves both the domestic Chinese market and international clients through its formulation sales and contract manufacturing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huason Pharmaceutical.